// App-Quantinova.ai

P4.057 : Tissue-engineered skin model derived from neurofibromatosis type 1 (NF1) patients to study tumor genesis and to predict response to therapy (P4.057)

Researchers

Presenter

  • Vincent Roy

Principal Investigators

  • Lydia Touzel-Deschnes

  • Edouard Marques

  • Peter Kannu

  • Helene Khuong

  • Nicolas Dupre

  • Francois Gros-Louis

Medical Centers

  • SickKids Hospital, Toronto, Canada

  • Neurology, CHU De Quebec (Enfant-Jesus) Quebec QC Canada

  • Neurology, CHU De Quebec (Enfant-Jesus) Quebec QC Canada

  • CHU de Quebec (LOEX) Québec QC Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • Neurofibromatosis type 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved